This Edition
ARTICLE | Clinical News
Celgosivir: Completed Phase II enrollment
WIR Staff
July 18, 2005 7:00 AM UTC
MGI completed the enrollment of 43 patients in its open-label, dose-ranging Phase II trial. ...